Pfenex Inc. (NYSEMKT:PFNX) belongs to Healthcare sector. Its weekly performance is 7.77%. On last trading day company shares ended up $21.64. Pfenex Inc. (NYSEMKT:PFNX) distance from 50-day simple moving average (SMA50) is 24.79%. On July 1, 2015, Pfenex Inc. (NYSEMKT:PFNX) and Wells Fargo Bank, National Association entered into an Amended and Restated Credit Agreement and an Amended and Restated Revolving Line of Credit Note. The Amended Credit Facility replaces the Company’s existing Credit Agreement, dated as of May 1, 2012 and Revolving Line of Credit Notes dated May 1, 2012 and June 24, 2013 (the “Existing Notes,” and together with the Exiting Credit Agreement, the “Existing Credit Facility”), between the Company and Wells Fargo.
Carrols Restaurant Group, Inc. (NASDAQ:TAST) shares advanced 5.73% in last trading session and ended the day at $10.89. TAST Gross Margin is 31.00% and its return on assets is -10.60%. Carrols Restaurant Group, Inc. (NASDAQ:TAST) quarterly performance is 33.29%. Investment analysts at Dougherty & Co hoisted their price targeton shares of Carrols Restaurant Group (NASDAQ:TAST) from $11.50 to $12.00 in a note issued to investors on Friday. The firm currently has a “buy” rating on the stock. Dougherty & Co’s price objective would indicate a potential upside of 13.96% from the stock’s previous close.
On 13 July, Wyndham Worldwide Corporation (NYSE:WYN) shares advanced 1.29% and was closed at $85.43. WYN EPS growth in last 5 year was 21.00%. Wyndham Worldwide Corporation (NYSE:WYN) year to date (YTD) performance is -0.38%. On 7 July, it was reported Wyndham Worldwide Corporation’s (NYSE:WYN) brand Wyndham Vacation Rentals has announced the acquisition of Canadian-based vacation rentals manager, ResortQuest Whistler. The acquisition marks the company’s debut in the country and adds almost 600 condominium units to its portfolio of vacation rental properties.
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) ended the last trading day at $131.93. Company weekly volatility is calculated as 7.73% and price to cash ratio as 33.00. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) showed a weekly performance of 65.41%. In a public conference call on Monday, Anacor Pharmaceuticals Inc (NASDAQ:ANAC) executives announced the results of two Phase 3 trials for a topical drug to treat atopic dermatitis, more commonly known as eczema. The treatment came in the form of a topical ointment, crisaborole.
Xylem Inc. (NYSE:XYL) shares moved up 1.89% in last trading session and ended the day at $36.06. XYL Gross Margin is 38.60% and its return on assets is 7.30%. Xylem Inc. (NYSE:XYL) quarterly performance is 2.95%.Xylem (NYSE: XYL) announced that Michael T. Speetzen, Senior Vice President and Chief Financial Officer, has resigned his position with the Company to accept another chief financial officer position, effective July 30, 2015.